Consider Subcutaneous Insulin to Manage DKA

July 2022

You’ll hear renewed debate about the optimal insulin regimen for treating diabetic ketoacidosis (DKA) in adults.

A recent retrospective study suggests that subcutaneous insulin, instead of IV, reduces ICU admissions...with no difference in hypoglycemia.

This adds to other limited data suggesting subcutaneous insulin is safe and effective for mild to moderate DKA.

Get concise advice on drug therapy, plus unlimited access to CE

Pharmacist's Letter membership benefits include:

  • 12 issues every year — what you need to know and do, right now
  • Quick, practical reference charts and tools
  • Comprehensive CE library to meet license renewal and state requirements
  • Multiple course formats including live webinars, podcasts, and CE-in-the-Letter to match your learning style
  • Plus much more!

Choose the right tier for your needs today.

Already a subscriber? Log in

Volume pricing available. Get a quote